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Accidental contamination of the food chain in Michigan in 1973 with polybrominated biphenyls
(PBBs) led to the establishment of a registry of exposed individuals in 1976. Seram was collected
and analyzed for PBB at the time of enrollment and for targeted studies in the following years.
We used the archived PBB data to study the elimination ofPBB and to identify factors associated
with elimination. A total of 380 women 2 16 years of age who had an initial PBB level of 2 ppb
and at least two serum samples drawn when they were not pregnant were induded in the analysis.
The mean initial PBB level was 20.9 ppb (median 4) and mean time between the first and last
measurement was 4.2 years (range 0.5-11.1). PBB was assumed to reach equilibrium in the body
before substantial amounts were eliminated and before the first serum measurements were taken;
therefore, the entire body was modeled as a single compartment for PBB with exponential decay.
Subject-specific decay rate estimates were regressed on predictor variables icluding initial age,
body mass index (BMI), smoking history, breast-feeding duration, and parity. In women with an
initial PBB level < 10 ppb, the median half-life was 12.9 years; in those with > 10 ppb, the medi-
an half-life was 28.7 years. Decay was sigificantly slower among women with an initial BMI at
or above the median (BMI . 23). The caculated half-life values are estimates of decay and can be
used to estimate body burden of PBB at various points in time other than at the time of serum
collection. Key wordk body mass index, decay, elimination, half-life, pharmacokinetics, poly-
brominated biphenyl. Environ Health Perspect 108:147-152 (2000). [Online 7 January 2000]
btph://ebpnetl.niebs.nihbov/docsA2000/108pl47-152blanck/abstracXthtmnln
A mixture of polybrominated biphenyls
(PBBs) was manufactured in the United
States in the early 1970s under the trade
name FireMaster (Michigan Chemical Co.,
St. Louis, MI). PBBs were used as fire retar-
dants for molded plastic parts, such as the
cases of televisions, typewriters, and business
machines. In 1973, an industrial accident
resulted in the inadvertent substitution of
FireMaster for NutriMaster (feed-grade
magnesium oxide), a nutritional supple-
ment, into livestock feed. In the following
months, many Michigan residents unknow-
ingly ate animal and dairy products that had
been contaminated with PBBs. Once the
PBB contamination was discovered, public
concern prompted assessment of possible
adverse health consequences in exposed indi-
viduals. A pilot study was conducted in
1974 and a registry of exposed individuals
was established in 1976. Details of the inci-
dent and the cohort have been described
previously (1-5).
There is renewed interest in the possible
human health effects of PBBs because of
their potential role as endocrine disruptors.
Endocrine-disrupting chemicals include a
family of structurally similar halogenated
organics that have the ability to mimic or
block normal hormonal activity. They are
widespread in occurrence, resistant to
degradation, and accumulate in fatty tissue.
These chemicals include DDT and its degra-
dation product DDE; 2,3,7,8-tetra-
chlorodibenzo-p-dioxin (TCDD); polychlo-
rinated biphenyls (PCBs); and PBBs. The
Michigan PBB cohort presents an opportu-
nity to study the elimination of one member
of this class ofcompounds from the body.
The Michigan contamination episode
involved a mixture of PBBs; however, the
main congener was 2,2',4,4',5,5'-hexabro-
mobiphenyl (6), which is called PBB153
under the numbering system of Ballschmiter
and Zell (7). Monitoring of rat feces has
shown that > 90% of an oral dose ofPBB 1 53
(dose range 1-30 mg/kg) is absorbed (8).
Results from numerous animal and in vitro
studies have shown that congeners with at
least four bromine atoms undergo little or no
metabolism in animals or humans (91; there-
fore, the Michigan individuals were mainly
exposed to virtually unchanged PBB153. In
the absence of metabolism, elimination is a
slow process. Some PBB is eliminated
through feces and hair. In women, PBB can
be eliminated through lactation. There is also
evidence that some PBB is transferred to off-
spring during pregnancy (4,10,11). The
highest PBB concentrations in the body are
found in adipose tissue, but it can also be
detected at lower concentrations in serum
and other lipid-rich tissues, such as the skin
and liver.
There are two previous reports of serum
PBB half-life in women. Both of these stud-
ies were conducted using data from the
Michigan PBB cohort (12,13). The Lambert
et al. (12) study was based on two serum
measurements from 15 women . 20 years of
age with an initial PBB level of at least 5 ppb
and whose previous value was greater than
the current value. This small study found a
median half-life of 12.0 years [95% confi-
dence interval (CI), 4-97]. The analysis by
Rosen et al. (13) included 51 women . 18
years of age with two to four PBB measure-
ments and an initial PBB level of at least 20
ppb. This study found a mean half-life of
13.0 years (CI, 6.3-infinite) and a median of
18.5 years (CI, 9.5-40.1). In the Rosen et al.
(13) study, the estimation of half-life dif-
fered in men (14.2 years) and women (infi-
nite years) in the highest quartile of body
mass index (BMI). Neither of these studies
examined the effect of breast-feeding dura-
tion, pregnancy, or smoking history on
PBB elimination.
The objective of the present analysis
was to determine the decay of PBB in the
serum ofwomen with a broad range ofPBB
levels and to determine whether a number
of covariates, such as age, BMI, smoking his-
tory, pregnancy, and breast-feeding dura-
tion, are associated with PBB elimination.
This analysis may also aid in understanding
the elimination of PCB153 (the analogous
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PCB congener), which is a major compo-
nent of human milk samples (ranging from
12 to 43% of total PCBs) (14,15).
Methods
Study population. From 1976 through
1978, the Michigan Department of Public
Health (Lansing, MI) enrolled into an expo-
sure registry > 4,000 persons who primarily
lived on or received food from farms that
had animals with at least 1 ppm PBB in milk
or tissue fat. During the initial enrollment,
informed consent was given, a health ques-
tionnaire was completed, and a serum sam-
ple was drawn and later analyzed for PBB
and other chemicals. Additional serum sam-
ples were drawn at other times from some
members of the cohort for various reasons,
including for use in follow-up studies per-
formed fiom 1982 through 1987 and for
additional tests at individuals' requests.
Cohort members with higher initial PBB
levels were more likely to have multiple mea-
surements because they were oversampled in
various follow-up studies (12). In 1997, a
total of 2,262 women in the registry had at
least one PBB measurement and 1,407
(62%) had two measurements. We used the
measurements from these 1,407 women for
the current study.
To be included in this study, a woman
had to have at least two serum PBB measure-
ments taken at least 6 months apart while the
woman was not pregnant, she had to have
been at least 16 years of age at the time of the
initial measurement, and she had to have had
an initial measurement of at least 2 ppb PBB
(Table 1). We chose 2 ppb because it is twice
the limit of detection (LOD) and allows
generalization of the results to the majority of
the cohort. The age and pregnancy criteria
were imposed because both may affect mea-
sured PBB levels (16,1]. The level ofPBB in
a child's serum decreases as the child grows
because of dilution caused by increasing body
weight. Pregnancy may cause the mobiliza-
tion of chemicals from storage tissue to
serum, resulting in inflated serum levels (16).
Using these criteria, 380 women were eligible
for this study. Samples for the initial PBB
Table 1. Female participants by inclusion criteria
in the Michigan PBB cohort eligible for the serum
PBB decay analysis.
No. Criteria
2,262 Females enrolled in the Michigan PBB cohort
1,407 At least two serum PBB measurements
950 Initial measurement . 2 ppb PBB
943 Initial and last measurements > 6 months
apart
737 At least 16 years of age at time of initial
measurement
380 Measurements known to not have been taken
during pregnancy
measurements were obtained from January
1976 to May 1980 and samples for the last
PBB measurements were obtained from
February 1977 to January 1988.
Information on covariates that were
thought to influence elimination of PBBs was
obtained primarily from a 1997 telephone
interview of participating adult female mem-
bers of the cohort. The interview included
detailed questions on pregnancies and breast-
feeding duration. Archived data were used to
obtain participant age, height, and weight at
initial PBB measurement, as well as smoking
status in 1976-1978, 1990-1994, and 1997.
BMI (in kilograms per square meter) was
used as the measure of adiposity at initial
PBB measurement.
PBB measurement. PBBs were measured
in human serum using gas chromatography
with electron capture detection (18-20).
The denatured serum sample first undergoes
an ether-ethyl or hexane-ether extraction
and is then passed through either a Florisil
or Florisil and silica gel column (20).
Quantitation of PBB was based on PBB1 53.
The size of this peak in the serum sample is
measured relative to the size of this peak in a
control sample containing a known weight
of FireMaster (18). The methods of PBB
detection used in this study have coefficients
of variation of 7.1-14.0% and recovery
ranges of 80-90% (18).
PBB levels < 1.0 ppb, the LOD, were
assigned a value of 0.5 ppb. This level was
chosen because it is halfway between zero
and the LOD and allows for log-
transformation of the data. This technique
was used previously in a study of PCB-
exposed women (21) and, in highly skewed
distributions (such as the present data), it is
an appropriate estimation technique (22).
Kinetic estimation. To explore the kinet-
ics of PBB elimination, we used a technique
known as the method of residuals or feather-
ing (23). We first graphed lnPBB1 tO ki
against time We then attempted to extrap-
olate the terminal straight-line portion of the
curve back to the taxis. We did this for the
serum PBB profiles of women with at least
five serum PBB measurements and at least
10 years between the first and last measure-
ments (n = 16). Inspection of the graphs for
these women did not reveal any evidence for
multiple body compartments involved in the
elimination of PBB from serum. This is con-
sistent with the data of Wolff et al. (24),
who showed that equilibrium between
serum and adipose tissue was probably
reached by 1976-2 years after exposure. All
of the serum measurements used in this
study were taken at least 2 years after expo-
sure. Because of a lack of multiple measure-
ments on women with low PBB levels, we
were not able to graphically assess whether
there was a dose-related transition from linear
to nonlinear kinetics.
Statistical analysis. Because there was no
apparent metabolism of PBB153 and there
were no serum measurements taken during
the initial distributional phase (24), we
modeled the entire body as a single compart-
ment for PBB; therefore, assuming a linear
one-compartment open model for PBB
elimination, the initial and subsequent
concentrations of PBB are therefore related
by the following formula:
Q t) = COe t
where qt) represents concentration at time
t, C0 represents PBB concentration at initial
time, and X is the rate of decay. If both sides
are log-transformed a linear relationship is
obtained: ln[Qt)] = ln(C0) - Xt. Thus, given
a set of successive PBB measurements, i.e.,
[C(tl), ..., Q)] on a participant at times[tl1..) QJ a rate constant, X, can be estimat-
ed from the slope of the linear regression of
ln[C(t)] versus t (25). The corresponding
half-life is then equal to tl12 = ln(2)/-A, the
time after which the original concentration
has been halved (26).
Using a linear regression of the natural
logarithm of all eligible PBB measurements
(range 2-9) versus the time since first level,
i.e., lnPBBI tO ki = Boi + B1,(time) + e.,we
estimated the overall decay rate (Xi =
-B,) for each woman. Because of its posi-
tively skewed distribution, the PBB level was
loge transformed for use as a continuous
variable in the regression analysis.
Table 2. Characteristics of PBB serum samples included in decay analysis.
Mean time between
Serum Samples Mean initial first and last
samples (n)a (frequency) Samples (%) PBB level (ppb) PBB level (years)
2 240 63.2 6.7 2.7
3 84 22.1 13.9 6.3
4 35 9.2 33.8 6.7
5 14 3.7 106.7 9.2
6 2 0.5 396.5 10.2
7 2 0.5 56.5 6.5
8 2 0.5 321.8 10.8
9 1 0.3 933.0 10.2
Total 380 100 20.9 4.2
aPer individual.
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To evaluate the predictive value of
covariates, the covariates were regressed
against the subject-specific decay rates (X5)
using multiple linear regression. Participants
who were missing information on any one of
the covariates were excluded from the analysis
(n = 41), resulting in a total of 339 women
for the multivariate analysis. The mean PBB
level among those participants with values
for all potential predictor variables was virtu-
ally identical to the mean PBB among those
participants missing at least one predictor
variable (5.52 vs. 5.75 ppb, t-test p = 0.84).
The covariates examined were initial PBB
level (continuous and tertiles); age at initial
measurement (continuous and categorized as
< 18, 18-50, and > 50 years of age); BMI at
initial measurement (continuous, median,
and tertiles); smoking history between first
and last measurement (ever- versus non-
smoker); number of full-term pregnancies
between first and last measurement (con-
tinuous and categories of 0, 1, and . 2); and
total breast-feeding duration in months
between first and last measurement (contin-
uous and tertiles). The total duration of
breast-feeding was calculated as the number
of months the child was fed mainly breast
milk plus half the number of months the
child was breastfed with supplementation.
This equation was based on work by Rogan
et al. (27) and Wickizer and Brilliant (28).
All main-effect variables were induded in
the initial model. All biologically plausible
two-way interaction terms were added to the
initial model to assess effect modification.
These terms included age x smoking status,
age x breast-feeding, age x initial PBB, BMI
x pregnancy, BMI x initial PBB, and breast-
feeding x initial PBB. We used a = 0.05 as a
cutoff for retaining variables in the model.
Covariates that altered the estimate for PBB
exposure by > 10% were retained in the
model as confounders. Alternate regression
models (e.g., second-order and spline mod-
els) were fitted to determine whether they
were more appropriate than a straight-line
model. Splines have been defined as segment-
ed (piecewise) polynomials of order r, which
agree up to derivatives of order 0, to r - 2 at
points where they join; the abscissas of these
joints are called knots or break points
(29,30). Splines allow modeling of two or
more lines or two or more parabolas in the
same regression model. In this analysis,
splines are used to describe the kinetics of low
PBB doses and to describe the possible depar-
ture of the higher PBB dose kinetics (31).
Knots for this analysis were based on visual
inspection of plots of mean decay versus PBB
level (i.e., the rate of decay increase was
roughly constant until it reached approxi-
mately the initial PBB level of 10 ppb, at
which point there was slowing of decay).
Partial F-tests and adjusted X2 comparisons
were used to assess whether alternative regres-
sion models were more appropriate than a
straight-line model. Collinearity and regres-
sion diagnostics were performed on the multi-
variate models of decay rate. Diagnostics
induded plots of both studentized and jack-
knife residuals versus the predicted value of
decay rate. The residual plots revealed eight
gross oudiers that were more than 3 SD from
the mean of the residuals. These outliers were
determined not to be data entry errors and
were removed from the multivariate analyses.
Plots of the residuals versus predicted value of
decay rate did not reveal any gross violations
of homoscedasticity. We analyzed Cook's dis-
tances and leverage values (h) for influential
predictor values. We also assessed delta betas
(the difference in the parameter estimate on
deletion of the corresponding observation) of
high leverage values. Variance inflation factors
and condition indices did not reveal collinear-
ity problems. The main effect covariates (age,
BMI, smoking status, breast-feeding duration,
and number of pregnancies) were kept in the
final model presented here because their influ-
ence on elimination, regardless of significance,
was a primary objective of this analysis. All
analyses were performed using SAS 6.12 (32.
Results
Descriptive PBB measurement information
for the 380 females in the study group is
shown in Table 2. Mean initial serum level
was 20.9 ppb (SD 78.7) and mean time
between first and last measurement was 4.2
years (range 0.5-11.1 years). A total of 140
(37%) of the 380 women had three or more
measurements. The mean age at the time of
the initial PBB sample was 33.7 years (range
16.0-75.2). Women with higher PBB levels
had a greater number of measurements.
A total of 109 females (29%) did not
have a reduction in serum PBB over time.
Table 3. Decay rates and corresponding half-life estimates for all eligible females by initial PBB level.
Decay rate (years-1) PBB half-life (years)
Initial PBB No. Mean Median Mean Cl Median Cl
2-4 ppb 205 -0.155 -0.086 4.5 3.5-6.2 8.1 5.1-infinite
5-10 ppb 99 -0.099 -0.069 7.0 4.6-15.0 10.1 7.2-13.5
11-20 ppb 31 -0.052 -0.032 16.2 7.3-80.1 29.8 16.2-infinite
21-1 00 ppb 32 -0.032 -0.023 21.6 17.4-28.5 30.8 14.7-73.5
> 100 ppb 13 -0.040 -0.026 17.5 9.5-106.7 27.2 12.1-212.3
Total 380 -0.118 -0.051 5.9 4.8-7.7 13.5 10.5-23.2
This was not a phenomenon restricted to the
lower concentrations, as might be expected
due to greater measurement error near the
LOD. The proportion of women with no
decay based on their initial PBB level were as
follows: < 4 ppb, 32.2%; 5-10 ppb, 23.2%;
11-20 ppb, 35.5%; 21-100 ppb, 18.7%;
and> 100 ppb, 23.1%.
The decay rate was slower, resulting in a
longer half-life, with higher initial PBB levels
(Table 3). Characteristics of the study popu-
lation for multivariate analyses are shown in
Table 4. Table 5 shows results for the final
multivariate model. Models with linear and
quadratic splines (with knots at 10 and/or
90 ppb) did not improve the fit of the model
(data not shown). A second-order polynomi-
al model of initial PBB level was more
appropriate than a straight-line model. We
found a slower PBB decay rate in women
with an initial BMI above the median (p =
0.03). The number of pregnancies was of
borderline significance (p = 0.06). A com-
parison of the number of pregnancies as a
continuous variable from 0 to 4 and as a
continuous variable by collapsing women
Table 4. Characteristics of serum PBB decay
study participants included in multivariate
regression models.
Variable No. %
Age
<18years 47 12.4
18-50 years 278 73.1
> 50 years 55 14.5
BMI
<23.0 188 49.9
> 23.0 189 50.1
Smoker
Never 324 85.3
Ever 56 14.7
Months breast-feeding
< 3 months 314 92.4
3-9 months 13 3.8
> 9 months 13 3.8
Pregnancies
0 292 76.8
1 63 16.6
2 18 4.7
3 5 1.3
4 2 0.5
Table 5. Results of the multivariate analysis of
predictors of serum PBB decay.
Predictor Parameter
variablea estimate SE p-Value
Intercept -0.227 0.044 0.001
Initial PBB level 0.031 0.028 0.269
(Initial PBB level)2 -0.002 0.005 0.663
BMIb 0.050 0.023 0.032
Pregnancies 0.038 0.021 0.064
Age (years) 0.001 0.001 0.122
Ever smokerc -0.031 0.029 0.288
Breastfed (months) -0.003 0.004 0.463
Effect of predictors on serum PBB yearly decay.
`Variables continuous if not noted. bBMI (0, < median; 1,
2 median). cEver smoked (0, no; 1, yes).
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with . 2 pregnancies (0-2) showed that
most of the effect of this variable on decay
rate is in women who had 3 or 4 pregnan-
cies. The effects ofBMI and pregnancy were
the same regardless of the model fitted.
Neither age nor smoking was associated
with serum decay ofPBB.
Weighting the estimates based on the
number of measurements per woman did
not substantially alter overall parameter esti-
mates. A sensitivity analysis of the full model
that excluded females < 18 years of age (n =
293) at the time of initial PBB measurement
did not result in appreciable differences in
parameter estimates; however, BMI was only
of borderline significance (p = 0.09), with a
reduction from 0.050 in the full model to
0.040 in the age-limited model. The esti-
mate for ever-smoking also changed from
-0.031 in the full model to -0.043 in the
age-limited model. To separate the effects of
pregnancy and breast-feeding, we analyzed
separately the data for women who did not
breast-feed. The analysis of women who did
not breast-feed (n = 295) resulted in similar
directionality of effect for each of the para-
meters; however, the parameter estimate was
slightly reduced for pregnancies from 0.039
(p = 0.06) in the full model to 0.033 (p =
0.18) in the stratified data.
Assessment of breast-feeding duration as
ever/never or tertiles of duration did not
appreciably alter the results. The parameter
estimates for breast-feeding (ever/never) was
0.0303 (p = 0.49). The parameter estimates
for the middle and upper tertiles of breast-
feeding duration were 0.0014 (p = 0.98) and
-0.0469 (p = 0.45), which were consistent
with the lack of effect on serum decay
observed with the continuous variable.
Half-life estimates of serum PBB in
women with various scenarios are shown in
Table 6. Two parts per billion is shown
because it reflects the median initial PBB
level among women actively participating in
the Michigan cohort in 1997.
Discussion
We estimated the decay rate of serum PBB
among women with multiple serum PBB
determinations between 1976 and 1988.
Thirty-seven percent of women had 2 3
serum PBB measurements and 29% of
women did not have a reduction in their
PBB values over time. Women with an initial
Table 6. Estimates of half-life in years for serum
PBB in women with various scenarios.
Initial serum
PBB (ppb)
2
5
2
5
Initial
BMI
<23
<23
.23
.23
Decay rate/
years
-0.169
-0.082
-0.119
-0.032
Half-life
(years)
4.10
8.45
5.82
21.7
PBB level < 10 ppb had a median half-life
for PBB of approximately 12.9 years and
women with an initial PBB level > 10 ppb
had a median half-life of approximately 28.7
years. We found that PBB decay was signifi-
cantly slower, resulting in a longer half-life,
in women with an initial BMI at or above
the median for this population (BMI . 23).
A borderline significant effect was observed
for the number of pregnancies. PBB decay
was slower and was inversely related to num-
ber of pregnancies. No significant change in
the decay estimate was observed with age,
smoking history, or breast-feeding duration.
The fact that a proportion of participants
showed no decline in measured PBB over
time is not surprising given the errors in mea-
surement and other unmeasured contribu-
tors to decay. These sources of unmeasured
error in our study include changes that could
result in a lack of serum decay over time.
These include changes in an individual's
weight, the lack of lipid adjustment or the
fact that the serum samples might not be
fasting, continued exposure to PBB, medica-
tion use by participants, and age-related
changes including lipid concentrations and
hepatic enzyme induction. We cannot elimi-
nate the possibility that some individuals
received continued exposure to PBB despite
public health interventions (e.g., manure
from some of the exposed cows could have
been left on the fields, leading to potential
subsequent exposure of replacement herds).
The unmetabolized PBB153 and its
analogous PCB congener have an average
half-life of at least 10 years (13,33). PBB, like
other highly persistent chemicals, is therefore
assumed to be in equilibrium among the
organs and tissues before substantial amounts
are eliminated (34) and was likely in equilib-
rium before the first serum measurements
were taken in participants of the PBB registry
(24). Wolff et al. (24) suggested that PBB
equilibrium should have been achieved in
the Michigan cohort by November 1976.
Consistent with equilibrium, graphs of log-
transformed serum PBB concentration versus
time in years (in candidate women) did not
suggest multicompartment effects; therefore,
a simple exponential decay model was used
in the current analysis. That longer half-lives
were found with higher initial PBB levels
suggests that PBB elimination may be a sat-
urable process at higher exposures resulting
in different distribution patterns or, more
likely, that there are unmeasured sources of
variability. In the latter case, there are exam-
ples where nonlinearity may be difficult to dis-
tinguish from experimental variability (23).
We do not believe that greater mea-
surement error near the LOD accounts for
the shortened half-life in women with low
initial PBB levels because the coefficients of
variation over a range of PBB concentrations
appear to be similar (18,19). Specifically,
Needham et al. (18) found coefficients of
variation for PBB of 8.4-13.8% for a target
value of 10 ppb, 14.0% for a target value of
41 ppb, 8.7% for a target value of 164 ppb,
and 7.1% for a target value of 484 ppb. In an
interlaboratory comparison of PBB detection
in human serum, Burse et al. (19) reported
that the Michigan Department of Public
Health (the agency that performed the PBB
measurement in the current study) had the
following coefficients of variation for serum
PBB: 3.2% for a target value of 5 ppb, 3.6%
for a target value of 25 ppb, 2.2% for a target
value of 50 ppb, 3.1% for a target value of 500
ppb, and 2.4% for a target value of 1,000 ppb.
A kinetic study could properly character-
ize the possible nonlinear elimination, much
like that done to assess trichloroethylene
(35). Previous PBB animal studies have
failed to use a range of dosing levels when
examining PBB elimination. A pharmacoki-
netic model in growing rats used a compart-
mental model to simulate the time course of
a dose of 1 mg/kg of PBB in rat tissues and
feces (36). Tissues examined included adi-
pose, skin, muscle, liver, and blood. Scaling
the model predictions to humans, this study
estimated a half-life of 6.5 years for humans.
In a separate rat study, the concentration of
PBB in serum and other tissues was deter-
mined in rats given a single dose of PBB (0.5
mg/kg). This study reported that elimination
of PBB from fat and serum in the rat fol-
lowed first-order kinetics (37).
Initial BMI values above the median
(. 23) for the study group was associated
with slower PBB decay, suggesting that there
is a greater retention of PBBs in women with
greater amounts of adipose tissue. Michalek
et al. (38) noted that this might be explained
by the affinity of the chemical for adipose tis-
sue. Rosen et al. (13) found an increased
PBB half-life with higher BMI in this cohort,
and increased PBB half-life with higher BMI
has also been found with TCDD, polychlori-
nated dibenzo-p-furans, and polychlorinated
dibenzo-p-dioxins (39,40).
Increasing parity between the first and
last PBB measurement was associated with
slower decay, but the effect was of borderline
significance. Because transplacental passage
from the mother to the fetus is expected to
be a minor route of PBB elimination, this
result was unexpected. It is possible that the
redistribution of PBB between organs and
serum due to pregnancy results in a period
postpartum during which serum PBB may
be increased or excretion of PBBs may be
reduced. It is also possible that weight gain
after pregnancy may increase the reservoir
for PBB storage and lengthen half-life.
Laden et al. (41) found elevated PCB levels
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in parous women, regardless of the number
of children and age at first birth, as compared
to nulliparous women (p = 0.00 1).
Breast-feeding as either a continuous
variable or as categorized by tertiles of dura-
tion (< 3 months, 3-9 months, or > 9
months) was not associated with decay.
Studies of PCBs have found decreases of
20-38% in maternal serum PCBs with each
6-month lactation period (42,43). A total of
35 of 85 women (41.2%) who had given
birth during the study period reported some
amount of breast-feeding between the first
and last PBB measurement; however, only
20 (6% of the multivariate study group)
reported a breast-feeding duration of at least
6 months.
This study found a median PBB half-life
of 13.5 years. Although there is lack of good
data on congener-specific PCBs, researchers
in one study of 39 occupationally exposed
workers in the United States collected serum
in 1976, 1979, and 1983 and found a geo-
metric mean serum half-life of 12.4 years for
PCB153 (33).
One strength of this study is that the
results can be generalized to the majority of
the female cohort members because we
included women at the lower range of the
observed dose of PBB; however, there are a
number of limitations to our analysis. In our
model, processes such as protein binding and
induction of cytochrome P450 enzymes were
not explicitly incorporated. In addition, 63%
of women had only two PBB measurements.
Because the majority ofwomen had only two
serum draws and some of the determinations
were taken at intervals < 1 half-life, the medi-
an half-life and its corresponding 95% confi-
dence interval is reported as a possibly less
biased estimate (44). The broad confidence
intervals around the median for women with
low initial PBB levels in Table 3 probably
reflect the short mean interval for these par-
ticular women (Table 2).
Lambert et al. (12) showed that among
members of the PBB cohort there was sub-
stantial variability in enzyme activity among
women, as assessed by the caffeine breath
test. Much of this variability may be due to
polymorphisms of the genes that regulate
metabolizing enzymes. In addition, age,
nutrition, hormone use, and hepatic disease
can affect microsomal substrate metabolism
(45,46). Studies concerning age and P450
enzyme activity are inconsistent and appear
to be substrate specific (47,48). Although age
was not a significant predictor of PBB decay
in our study, Flesch-Janys et al. (39) found
that increasing age was related to increasing
half-life of polychlorinated dibenzo-p-
dioxins and dibenzofurans. These authors
suggest that age affected P450 (specifically
CYP lAI and CYP 1A2) induction. We did
not have data on nutrition, medication, or
oral contraceptive use.
We lacked information on changes in
weight over time. When rats are fed a single
dose of PCB153 and there is no change in
weight, the decay is first-order with reversible
storage and total elimination (49). In rats
with a shrinking adipose compartment, the
fecal excretion rate increased up to 10-fold
and the skin became an alternative storage
depot (50). Wyss et al. (50) concluded that
irreversible storage and limited elimination
in the rat was due to steady enlargement of
the adipose tissue compartment over time.
Because weight was not assessed at each of
the serum draws, we only have initial BMI as
a measure of adiposity, and we were not able
to assess the effect of change in adiposity on
decay. It is possible that large fluctuations in
adipose tissue mass due to intentional or
unintentional weight loss, resulting in redis-
tribution between adipose and serum levels,
might result in a lack of serum PBB decline
over time. In studies of TCDD, neither
reported weight loss nor relative change in
percent body fat were associated with serum
TCDD levels over time or TCDD decay,
respectively (40). However, Zober and
Papke (51) found that after severe weight
loss, such as cancer cachexia, blood levels of
2,3,7,8-TCDD increased. At autopsy of
dioxin-exposed individuals who died from
cancer and had reported weight loss in the
months before death, blood levels of 2,3,7,
8-TCDD increased from 17 to 32 ppt in
one individual and from 518 to 7,482 ppt in
another individual. The preautopsy blood
levels were taken 5 and 8 months before
death, respectively. Because regulation of fat
mobilization is not well understood, further
study of this phenomenon is needed to
determine how organisms handle unmetabo-
lizable and persistent compounds (52).
Another possible limitation of the data
is that participants were not given instruc-
tions about fasting before the serum draw.
There is no record of fasting status, and
PBB levels were not corrected by total
lipids. Phillips et al. (53) observed higher
nonfasting levels of serum PCBs as com-
pared to fasting serum samples. It is possible
that the lack of lipid adjustment is likely to
add a small amount of error to the PBB
measurement in the current study, poten-
tially resulting in slower or stable half-lifes.
That PBB decline was not related to age in
our data argues that an age-related lipid
effect is extremely small.
The PBB detection methods used in this
study have changed over time. During the
years 1976-1978, the extraction method
was used to detect PBBs. From 1978 to
1982 the dual determination (combined)
method was used to detect both PBBs and
PCBs. Starting in 1982, the pesticide scan
method was used to detect PBBs, DDE,
DDT, oxychlordane, trans-nonachlor, and
mirex. Although the methods have changed
over time, Kreiss et al. (54), who compared
the extraction and dual determination
methods, concluded that there was no dif-
ference in PBB concentration obtained by
the two methods. Specifically, they reana-
lyzed serum samples collected in 1977 by
the combined method (n = 1,622) and
serum samples collected in 1978 by the
extraction method (n = 609) to determine
the comparability of the results obtained.
The median difference between the 1,622
paired PBB samples analyzed by the two
methods was zero; the median difference in
609 paired PBB levels by extraction and
combined method was also zero. The pesti-
cide scan method was used for better separa-
tion ofDDE from PCBs, with no change in
detection of PBB.
We estimated a mean PBB half-life for
women in this study with an initial level of
20 ppb as 20.8 years (CI, 14.9-34.6 years)
and median half-life as 28.7 years (22.3-
41.04 years). Rosen and colleagues (13)
reported a mean half-life of 13.0 years (CI,
6.3-infinite) and median half-life of 18.5
years (CI 9.5-40.1). Differences in inclusion
criteria may account for the differences in
half-life found in this study as compared to
that found by Rosen et al. (13), who used
only samples taken before 1983. Rosen et al.
(13) had a sample size of 51, with a maxi-
mum of four measurements for any one
participant and a 6-year maximum time
between measurements. Rosen's study
assessed whether initial PBB level, first year
of measurement, BMI, and age were predic-
tors of the decay rate. Only BMI was predic-
tive of decay. The estimated half-life for
women in the highest quartile of BMI was
infinite. It is not surprising that initial PBB
level was not an important predictor in the
Rosen et al. (13) study because the inclusion
criteria limited the analysis to women with
an initial PBB level of at least 20 ppb. We
found similar half-lives for women with a
broad range of initial PBB levels > 21 ppb.
The model developed here may be useful
to other researchers who are interested in
reconstructing exposure levels to PBBs or to
similar organochlorines. In studies of individ-
uals for whom a single serum level is avail-
able, the level of chemical at times other than
when the serum was collected may be esti-
mated by use of such a model. Because analo-
gous PBB and PCB congeners are expected
to have similar toxicokinetics, the results of
this study also may be relevant to studies
involving the more highly chlorinated PCB
congeners, particularly the commonly occur-
ring congener PCB 1 53.
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